Idogen: Explores a new project
Idogen today announced that they are pursuing a project for their IDO cell therapy approach in an autoimmune disease. We do not know many details currently but pre-clinical data could be presented within 3-6 months.
Idogen today announced that they are pursuing a project for their IDO cell therapy approach in an autoimmune disease. We do not know many details currently but pre-clinical data could be presented within 3-6 months.
Börskollens app – Högt betyg ⭐⭐⭐⭐⭐ och 250.000 nedladdningar
Ladda hemVårt nyhetsbrev – Utvalda börsnyheter och heta investeringscase varje vecka
PrenumereraJämförelse: Så får du bästa räntan just nu!
Tabellen presenteras tillsammans med Compricer som jämför aktuella räntor för olika bindningstider. Klicka dig gärna vidare för att läsa mer.